<DOC>
	<DOCNO>NCT01985958</DOCNO>
	<brief_summary>Primary Objective : To estimate rate radiotherapy primary metastatic lesion produce immune response patient metastatic carcinoma pancreas . Secondary Objectives : To characterize kinetics immune response induce radiotherapy . To characterize dependency immune response prior exposure chemotherapy .</brief_summary>
	<brief_title>A Pilot Study Evaluate Radiotherapy-Induced Anti-Tumor Immunity Metastatic Carcinoma Pancreas</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<criteria>Histological cytological diagnosis pancreatic carcinoma Patients ≥ 18 year age Eastern Cooperative Oncology Group ( ECOG ) performance status 0,1 , 2 Patients must distant metastatic disease ( stage 4 ) Satisfactory organ bone marrow function define : Absolute neutrophil count &gt; 1,000/uL , Platelets &gt; 75,000uL Hemoglobin &gt; 9 Bilirubin ≤ 2.0x institutional normal upper limit unless secondary bile duct obstruction tumor , Creatinine ≤ 1.5x institutional normal upper limit Serum alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) ≤ 5x institutional normal upper limit . A clinical recommendation radiotherapy primary metastatic lesion make . Must able provide inform consent . No prior radiation area plan radiotherapy Active invasive cancer pancreatic adenocarcinoma . Nonmelanoma skin cancer , superficial cervical bladder cancer prostate cancer PSA level &lt; 1.0 exclude . Known HIV , HCV and/or HBV positive ( patient report/medical record ) Patients ongoing active infection Planned concurrent treatment systemic high dose corticosteroid . Received anticancer treatment ( systemic therapy radiation therapy ) within 21 day prior enrollment . Immunotherapy ( e.g . monoclonal antibody ) within 21 day prior enrollment . Immunosuppressive therapy ( e.g . steroid , cyclosporine ) permit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>